|
| ||
|
|
||
Cell Load (cell + load)
Selected AbstractsHuman tissue-engineered bone produced in clinically relevant amounts using a semi-automated perfusion bioreactor system: a preliminary studyJOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, Issue 1 2010F. W. Janssen Abstract The aim of this study was to evaluate a semi-automated perfusion bioreactor system for the production of clinically relevant amounts of human tissue-engineered bone. Human bone marrow stromal cells (hBMSCs) of eight donors were dynamically seeded and proliferated in a perfusion bioreactor system in clinically relevant volumes (10 cm3) of macroporous biphasic calcium phosphate scaffolds (BCP particles, 2,6 mm). Cell load and distribution were shown using methylene blue staining. MTT staining was used to demonstrate viability of the present cells. After 20 days of cultivation, the particles were covered with a homogeneous layer of viable cells. Online oxygen measurements confirmed the proliferation of hBMSCs in the bioreactor. After 20 days of cultivation, the hybrid constructs became interconnected and a dense layer of extracellular matrix was present, as visualized by scanning electron microscopy (SEM). Furthermore, the hBMSCs showed differentiation towards the osteogenic lineage as was indicated by collagen type I production and alkaline phosphatase (ALP) expression. We observed no significant differences in osteogenic gene expression profiles between static and dynamic conditions like ALP, BMP2, Id1, Id2, Smad6, collagen type I, osteocalcin, osteonectin and S100A4. For the donors that showed bone formation, dynamically cultured hybrid constructs showed the same amount of bone as the statically cultured hybrid constructs. Based on these results, we conclude that a semi-automated perfusion bioreactor system is capable of producing clinically relevant and viable amounts of human tissue-engineered bone that exhibit bone-forming potential after implantation in nude mice. Copyright © 2009 John Wiley & Sons, Ltd. [source] Assessment of the access selection gain in multi-radio access networksEUROPEAN TRANSACTIONS ON TELECOMMUNICATIONS, Issue 3 2009Joachim Sachs In this paper, we investigate the capacity gain of access selection in a multi-radio access network with heterogeneous radio access technologies (RATs). We classify the kinds of gain that can be achieved by access selection: statistical multiplexing in the multi-access system leads to a trunking gain, spatial transmission diversity results from the geographic capacity distribution of the cell layout, stochastic transmission diversity exploits the multi-path fading characteristics. We show how these different properties are affected by the cell layout of the different RATs, the characteristics of each RAT and the traffic load distribution in the network. In a simulation environment the system capacity for the combination of two wide-area access technologies, as well as, for the combination of a wide-area and a local-area access technology is investigated. For this, we compare two different access selection algorithms. One uses the radio link quality as an input parameter, while the other also considers the cell load. We derive quantitative figures for the capacity gain in a large number of scenarios and show that load-based access selection can significantly increase the capacity. We show that the gain of an overlay of local-area access cells provides little capacity gain for uniform geographic load distribution, whereas significant gain can be achieved when most users are located at hotspots. Copyright © 2007 John Wiley & Sons, Ltd. [source] Thymol and modified atmosphere packaging to control microbiological spoilage in packed fresh cod hamburgersINTERNATIONAL JOURNAL OF FOOD SCIENCE & TECHNOLOGY, Issue 8 2009Maria Rosaria Corbo Summary A study on the use of mild technologies to produce packaged fish hamburgers was presented. In particular, the antimicrobial effect of some natural compounds (carvacrol, eugenol, thymol, green tea extract, rosemary extract, grapefruit seed extract and lemon extract), at various concentrations (500,10 000 ppm), was screened in vitro against the main fish spoilage micro-organisms (Shewanella putrefaciens and Photobacterium phosphoreum). Lemon extract and thymol, in combination with modified atmosphere packaging, showed the greatest inhibition activity, therefore, thymol was subsequently used as an ingredient for producing fish hamburgers. Results pointed out that this combination is effective in controlling the growth of microbial species mainly involved in fresh fish spoilage; in particular, it significantly (P < 0.05) reduced the growth rate of bacterial population, performing about 4.8 log CFU g,1 and 6.5 log CFU g,1 reduction of the hydrogen sulphide producing bacteria and psychrotrophic aerobic specific spoilage organisms cell load, respectively, if compared with the control. [source] Increased cellular hypoxia and reduced proliferation of both normal and leukaemic cells during progression of acute myeloid leukaemia in ratsCELL PROLIFERATION, Issue 6 2000P.Ø. Jensen The microenvironmental changes in the bone marrow, spleen and liver during progression of the transplantable promyelocytic leukaemia in the Brown Norwegian rat (BNML) have been studied. We used flow cytometry to estimate cellular hypoxia and proliferation based on in vivo pulse-labelling with a mixture of 2-nitroimidazole linked to theophylline (NITP) and bromodeoxyuridine (BrdUrd). The leukaemic cells were identified with the RM124 antibody. In rats inoculated with leukaemic cells the fraction of RM124+ cells was significantly increased from day 20 onwards in the spleen and from day 27 in the bone marrow and liver, reaching a level of 65,87% in these organs at day 32. At day 32, the NITP+ fraction of RM124+ cells had increased significantly in the bone marrow and spleen to 88% and 90%, respectively. The corresponding fractions of NITP+ normal cells reached 63% and 65%, respectively. From day 13 to day 32, the DNA-synthesizing (BrdUrd+) fraction of RM124+ cells in the bone marrow decreased significantly from 52% to 25%, and of normal cells from about 20% to 6%. In the bone marrow and spleen at day 27 and 32, the S-phase and G2/M-phase fractions according to DNA content were higher for the NITP+ than for the NITP, cells. This could partly be explained by an impaired cell cycle progression due to hypoxia. Nevertheless, we found indications of leukaemic cells that were simultaneously labelled with NITP and BrdUrd, in the bone marrow and spleen. These latter findings suggest that in contrast to normal cells some of the leukaemic cells can proliferate even during hypoxia, and this subpopulation may consequently renew and expand the leukaemic cell load. [source] Serum concentration of baseline mast cell tryptase: evidence for a decline during long-term immunotherapy for Hymenoptera venom allergyCLINICAL & EXPERIMENTAL ALLERGY, Issue 4 2010S. Dugas-Breit Summary Background Baseline serum mast cell tryptase concentration (BTC) is thought to reflect the constitutive mast cell load or activity of an individual patient. Little is known about the individual stability of BTC during long-term venom immunotherapy (VIT). Objective To investigate the intra-individual stability of BTC over time in patients with Hymenoptera venom allergy. Methods Three hundred and two patients were studied. BTC was measured before and at least twice during VIT. At least 4 weeks lay between BTC measurements and the most recent field sting, in-hospital sting, or preceding venom injection. Multifactorial mixed linear models were used to analyse BTC changes over time. Results Median observation time was 4.2 years (range 2,12 years). Before VIT, the median BTC was 6.8 ,g/L (range 1.14,177 ,g/L). The median coefficient of variation (CV) over time was 15.3% (range 1.9,63.8%). The median CV was significantly smaller in patients presenting with an elevated BTC (>11.4 ,g/L) than in patients with a normal BTC (11.4%, range 2.6,39.5%; vs. 17.6%, range 1.9, 63.8%; P<0.001). During VIT and after adjusting for age and gender, we found a slight but significant decrease of BTC over time (2.5% per year, 95% confidence interval 2.0,3.0%, P<0.001). Conclusion Individual variation of BTC during VIT does not rise when BTC is increased before therapy. VIT is associated with a small, but continuous decrease of BTC over time possibly indicating a dampened mast cell function or a decline in mast cell burden. Cite this as: S. Dugas-Breit, B. Przybilla, M. Dugas, A. Arnold, G. Pfundstein, H. Küchenhoff and F. Ruëff, Clinical & Experimental Allergy, 2010 (40) 643,649. [source] | ||||||||||